Literature DB >> 28508417

Score of Toxic Epidermal Necrosis Predicts the Outcomes of Pediatric Epidermal Necrolysis.

Jennifer Sorrell1,2, Lisa Anthony1, Alfred Rademaker3, Steven M Belknap1,4, Shields Callahan1, Dennis P West1, Amy S Paller1,2.   

Abstract

BACKGROUND/
OBJECTIVES: Epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis) includes immune-mediated, life-threatening inflammatory blistering disorders that can affect children. The Score of Toxic Epidermal Necrosis (SCORTEN) tool has accurately predicted the outcome of these disorders in adults but has not been tested in children.
METHODS: We performed a retrospective chart review to compare the accuracy of the adult SCORTEN tool with that of two modifications tailored to children in predicting disease outcome.
RESULTS: The longer the patient's median length of hospital stay was, the higher the adult and two proposed pediatric SCORTENs were. In addition, all patients who died had SCORTENs greater than 4.
CONCLUSION: The pediatric-modified tools were not superior to the adult SCORTEN, which accurately predicted outcome.
© 2017 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2017        PMID: 28508417     DOI: 10.1111/pde.13172

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  7 in total

Review 1.  Toxic Epidermal Necrolysis and Steven-Johnson Syndrome: A Comprehensive Review.

Authors:  Olivia A Charlton; Victoria Harris; Kevin Phan; Erin Mewton; Chris Jackson; Alan Cooper
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-01-09       Impact factor: 4.730

Review 2.  Management of Drug-Induced Epidermal Necrolysis (DEN) in Pediatric Patients: Moving from Drug-Induced Stevens-Johnson Syndrome, Overlap and Toxic Epidermal Necrolysis to a Single Unifying Diagnosis of DEN.

Authors:  Michele L Ramien; Danny Mansour; Neil H Shear
Journal:  Paediatr Drugs       Date:  2022-06-09       Impact factor: 3.022

Review 3.  Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Authors:  Marianne Lerch; Carlo Mainetti; Benedetta Terziroli Beretta-Piccoli; Thomas Harr
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 10.817

4.  Stevens-Johnson syndrome/toxic epidermal necrolysis associated with zonisamide.

Authors:  Karina L Vivar; Kimberly Mancl; Lucia Seminario-Vidal
Journal:  Clin Case Rep       Date:  2017-12-20

5.  Clinical and Epidemiological Features of Patients with Drug-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Iran: Different Points of Children from Adults.

Authors:  Bahareh Abtahi-Naeini; Mohammad-Sadegh Dehghan; Fatemeh Paknazar; Zabihollah Shahmoradi; Gita Faghihi; Ali Mohammad Sabzghabaee; Mojtaba Akbari; Mahdi Hadian; Tooba Momen
Journal:  Int J Pediatr       Date:  2022-02-08

6.  The role of treatment with plasma exchange therapy in two pediatric toxic epidermal necrolysis cases related to COVID-19.

Authors:  Fatih Varol; Yasar Yusuf Can; Ebru Sahin; Cansu Durak; Aziz Kilic; Ceyhan Sahin; Fatima Gursoy; Tugba Akin
Journal:  J Clin Apher       Date:  2022-07-06       Impact factor: 2.605

7.  A 7-year-old boy with toxic epidermal necrolysis, heart failure, and sepsis treated with the guidance of invasive hemodynamic monitoring: A case report.

Authors:  Amir Saeed; Nima Mehdizadegan
Journal:  Clin Case Rep       Date:  2021-07-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.